Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.44 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 157.40K shares, a 88.90% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 5.28M shares, a 22.81% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 23.00K shares, a 62.30% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 7.40M shares, a 16.05% increase from fiscal 2022.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 6.38M shares, a 23.14% increase from fiscal 2021.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 5.18M shares, a 7.19% decline from fiscal 2020.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 5.58M shares, a 211.54% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 157.40K shares derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | 5.44M shares 10-Q · filed 2026-08-06 | 5.46M shares derived: sum of 3 quarters · filed 2026-08-06 | 5.46M shares derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | 5.28M shares S-1 · filed 2026-05-08 | 5.30M shares derived: sum of 2 quarters · filed 2026-05-08 | 5.30M shares derived: sum of 3 quarters · filed 2026-05-08 | 6.72M shares derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2025-12-31 | 23.00K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | 23.00K shares derived: sum of 2 quarters · filed 2026-05-08 | 1.44M shares derived: sum of 3 quarters · filed 2026-05-08 | 8.28M shares S-1 · filed 2026-05-08 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 1.42M shares derived: sum of 2 quarters · filed 2025-11-13 | 8.26M shares 10-Q · filed 2025-11-13 | 8.32M shares derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2025-06-30 | 1.42M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 8.26M shares 10-Q · filed 2025-08-13 | 8.32M shares derived: sum of 3 quarters · filed 2026-05-08 | 8.34M shares derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2025-03-31 | 6.84M shares 10-Q · filed 2025-05-13 | 6.90M shares derived: sum of 2 quarters · filed 2026-05-08 | 6.92M shares derived: sum of 3 quarters · filed 2026-05-08 | 7.42M shares derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | 61.00K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | 82.50K shares derived: sum of 2 quarters · filed 2026-05-08 | 574.50K shares derived: sum of 3 quarters · filed 2026-05-08 | 5.31M shares S-1 · filed 2026-05-08 | ||
| 2024-09-30 | 21.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 513.50K shares derived: sum of 2 quarters · filed 2024-11-13 | 5.25M shares 10-Q · filed 2024-11-13 | 5.25M shares derived: sum of 4 quarters · filed 2025-03-20 | ||
| 2024-06-30 | 492.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 5.23M shares 10-Q · filed 2024-08-08 | 5.23M shares derived: sum of 3 quarters · filed 2025-03-20 | |||
| 2024-03-31 | 4.73M shares 10-Q · filed 2024-05-13 | 4.73M shares derived: sum of 2 quarters · filed 2025-03-20 | ||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 7.40M shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 7.40M shares 10-Q · filed 2023-11-02 | |||||
| 2023-03-31 | 7.36M shares 10-Q · filed 2023-08-03 | 6.96M shares 10-Q · filed 2023-05-04 | 7.96M shares derived: sum of 2 quarters · filed 2024-03-14 | 9.11M shares derived: sum of 3 quarters · filed 2024-03-14 | 10.50M shares derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-12-31 | 599.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 1.75M shares derived: sum of 2 quarters · filed 2024-03-14 | 3.14M shares derived: sum of 3 quarters · filed 2024-03-14 | 6.38M shares 10-K · filed 2024-03-14 | ||
| 2022-09-30 | 1.15M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 2.54M shares derived: sum of 2 quarters · filed 2022-11-09 | 5.78M shares 10-Q · filed 2022-11-09 | 6.83M shares derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2022-06-30 | 1.39M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 4.63M shares 10-Q · filed 2022-08-08 | 5.68M shares derived: sum of 3 quarters · filed 2023-03-15 | 7.29M shares derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2022-03-31 | 3.24M shares 10-Q · filed 2022-05-09 | 4.30M shares derived: sum of 2 quarters · filed 2023-03-15 | 5.90M shares derived: sum of 3 quarters · filed 2023-03-15 | 7.26M shares derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-12-31 | 1.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 2.66M shares derived: sum of 2 quarters · filed 2023-03-15 | 4.02M shares derived: sum of 3 quarters · filed 2023-03-15 | 5.18M shares 10-K · filed 2023-03-15 | ||
| 2021-09-30 | 1.61M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 2.96M shares derived: sum of 2 quarters · filed 2021-11-04 | 4.12M shares 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | 1.35M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 2.52M shares 10-Q · filed 2021-08-05 | ||||
| 2021-03-31 | 1.16M shares 10-Q · filed 2021-05-06 | |||||
| 2020-12-31 | 5.58M shares 10-K · filed 2022-02-24 | |||||
| 2020-03-24 | 2.61M shares 10-K · filed 2021-02-25 | |||||
| 2019-12-31 | 377.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 377.44K shares derived: sum of 2 quarters · filed 2022-02-24 | 1.79M shares 10-K · filed 2022-02-24 | |||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 1.41M shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 1.41M shares 10-Q · filed 2019-08-08 | |||||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 0.00 shares derived: sum of 2 quarters · filed 2021-02-25 | 431.10K shares 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 431.10K shares 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | 431.10K shares 10-Q · filed 2018-08-10 | |||||
| 2017-12-31 | 78.41K shares 10-K · filed 2019-02-06 | |||||
| 2017-06-30 | 1.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | 3.58M shares 10-K · filed 2017-09-01 | ||||
| 2017-03-31 | 2.39M shares 10-Q · filed 2017-05-08 | |||||
| 2016-09-30 | 1.31M shares 10-Q · filed 2016-11-08 | |||||
| 2016-06-30 | 1.64M shares 10-K · filed 2017-09-01 | |||||
| 2015-09-30 | 1.05M shares 10-Q · filed 2015-11-06 | 1.12M shares derived: sum of 2 quarters · filed 2016-09-13 | 1.20M shares derived: sum of 3 quarters · filed 2016-09-13 | 2.25M shares derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2015-06-30 | 77.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | 157.00K shares derived: sum of 2 quarters · filed 2016-09-13 | 1.21M shares derived: sum of 3 quarters · filed 2016-09-13 | 1.43M shares 10-K · filed 2016-09-13 | ||
| 2015-03-31 | 80.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | 1.13M shares derived: sum of 2 quarters · filed 2015-05-08 | 1.35M shares 10-Q · filed 2015-05-08 | 1.60M shares derived: sum of 4 quarters · filed 2015-05-08 | ||
| 2014-12-31 | 1.05M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | 1.27M shares 10-Q · filed 2015-02-06 | 1.52M shares derived: sum of 3 quarters · filed 2015-02-06 | 1.59M shares derived: sum of 4 quarters · filed 2015-02-06 | ||
| 2014-09-30 | 225.00K shares 10-Q · filed 2014-11-07 | 470.00K shares derived: sum of 2 quarters · filed 2014-11-07 | 535.25K shares derived: sum of 3 quarters · filed 2014-11-07 | |||
| 2014-06-30 | 245.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-30 | 310.25K shares derived: sum of 2 quarters · filed 2014-09-30 | 912.98K shares 10-K · filed 2014-09-30 | |||
| 2014-03-31 | 65.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | 667.98K shares 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | 602.73K shares 10-Q · filed 2014-02-10 | |||||
| 2013-06-30 | 1.17M shares 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |